Concert Pharmaceuticals, Inc. announced that Thomas G. Auchincloss, Jr. will join it's board of directors and serve as the independent chair of the board and audit committee, effective immediately. Auchincloss replaces Helmut Schühsler as chair of the audit committee. Dr. Schühsler will remain a member of Concert's board of directors.

Auchincloss is a financial expert and seasoned corporate financial executive. He has more than thirty years of financial experience including more than twenty years biotechnology experience in executive level financial, operational and advisory roles. Auchincloss is the former chief financial officer of Metabolix, Inc. Before joining Metabolix, he held a variety of positions at Vertex Pharmaceuticals, Inc. most recently as vice president, finance and treasurer.

Auchincloss is presently the managing partner of Counterpoint Trading Company LLC. He also serves as a trustee and treasurer of Kieve Wavus Education, Inc. and as an advisor to Capital Formation Group, Inc. and Acelium.